Steris PLC (BSP:S1TE34)
R$ 60 6.95 (13.1%) Market Cap: 118.58 Bil Enterprise Value: 133.52 Bil PE Ratio: 61.78 PB Ratio: 3.69 GF Score: 33/100

Steris plc at Raymond James Institutional Investors Conference Transcript

Mar 02, 2020 / 12:30PM GMT
Lawrence Soren Keusch
Raymond James & Associates, Inc., Research Division - MD

Okay. Good morning, everyone. Welcome to the Annual Raymond James Institutional Investors Conference.

We're excited to have with us this morning, kicking off the meeting this year, STERIS. STERIS has really seen some terrific growth over the last year and change. They have really seen all parts of their businesses firing on all cylinders, driving margin expansion and deploying capital effectively, so extremely well positioned.

With us today to give an update on the story is Mike Tokich. Mike is the Senior Vice President and Chief Financial Officer at STERIS; and in the audience is Julie Winter, who is the Director of Investor Relations and Corporate Communications. So with that, Mike, I'll turn it over to you.

Michael J. Tokich
STERIS plc - Senior VP & CFO

Great. Thank you, Larry. Good morning, everybody. It's my pleasure to be here to talk about one of my favorite subjects, STERIS. As Larry said, we've had a fantastic year. Our year does end in less

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot